https://www.marketscreener.com/news/pacira-biosciences-shareholder-seeks-board-changes-pushes-for-sale-ce7e59d8d88ef226
Pacira Biosciences shareholder, DOMA Perpetual Capital Management, said Tuesday that it plans to nominate three independent director candidates at the...
pacira biosciencesboard changesshareholderseekspushes
https://www.marketscreener.com/news/pacira-biosciences-inc-announces-agreement-with-lg-chem-to-make-exparel-available-in-select-asian-ce7e58dbde8af521
Pacira BioSciences, Inc. announced it has entered into an agreement with LG Chem designed to expand access to opioid-sparing postsurgical pain control for...
pacira bioscienceslg chemincannouncesagreement
https://www.fiercebiotech.com/medtech/pacira-pours-up-to-25m-into-surgical-reconstruction-player-tela-bio
Pacira Pharmaceuticals has signed on to invest up to
pacirapourssurgicalreconstructionplayer
https://www.foxbusiness.com/markets/pacira-pharma-skids-as-fda-refuses-to-grant-new-clearance-for-post-surgery-pain-drug-exparel
Shares of Pacira Pharmaceuticals tumbled Monday after the company said regulators refused to grant a new marketing approval for its post-surgical pain drug...
new clearancepacirapharmaskidsfda
https://www.marketscreener.com/news/pacira-biosciences-inc-reports-preliminary-unaudited-revenue-results-for-the-year-ended-december-3-ce7e59d2d98af020
Pacira BioSciences, Inc. reported preliminary unaudited revenue results for the year ended December 31, 2025. For the period, the company reported total...
pacira biosciencesincreportspreliminaryrevenue